ELV
insider transactionsElevance Health, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-2.1K
0 buy · 2.1K sell
Net value · 90d
-$826.6K
$0 in · $826.6K out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
3
0 buy · 2.1K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
CAO & Controller
$148.8K
369 sh · $403.16
Own -9%
-
Sell·S
Director
$60.7K
151 sh · $401.77
Own -1%
-
Exercise·M
CAO & Controller
$0
877 sh
Own New
-
Exercise·M
CAO & Controller
$0
654 sh
Own New
-
Sell·S
CAO & Controller
$617.2K
1.5K sh · $403.13
Own -27%
-
Exercise·M
CAO & Controller
$273.2K
877 sh · $311.48
Own +18%
-
Exercise·M
CAO & Controller
$177.4K
654 sh · $271.27
Own +16%
-
Grant·A
Director
$0
563 sh
Own +12%
-
Grant·A
Director
$0
563 sh
Own +11%
-
Grant·A
Director
$0
563 sh
Own +34%
-
Grant·A
Director
$0
563 sh
Own +258%
-
Grant·A
Director
$0
563 sh
Own +9%
-
Grant·A
Director
$0
563 sh
Own +6%
-
Grant·A
Director
$0
563 sh
Own +5%
-
Grant·A
Director
$0
563 sh
Own +5%
-
Grant·A
Director
$0
563 sh
Own +15%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Ronald W Penczek | Sell S | 369 | $148.8K |
| Jun 11, 2026 | Robert L Dixon JR | Sell S | 151 | $60.7K |
| May 19, 2026 | Ronald W Penczek | Exercise M | 877 | $0 |
| May 19, 2026 | Ronald W Penczek | Exercise M | 654 | $0 |
| May 19, 2026 | Ronald W Penczek | Sell S | 1.5K | $617.2K |
| May 19, 2026 | Ronald W Penczek | Exercise M | 877 | $273.2K |
| May 19, 2026 | Ronald W Penczek | Exercise M | 654 | $177.4K |
| May 13, 2026 | Bahija Jallal | Grant A | 563 | $0 |
| May 13, 2026 | Antonio F Neri | Grant A | 563 | $0 |
| May 13, 2026 | Deanna D Strable-Soethout | Grant A | 563 | $0 |
| May 13, 2026 | Amy W Schulman | Grant A | 563 | $0 |
| May 13, 2026 | Ryan M. Schneider | Grant A | 563 | $0 |
| May 13, 2026 | Ramiro G Peru | Grant A | 563 | $0 |
| May 13, 2026 | Lewis Hay III | Grant A | 563 | $0 |
| May 13, 2026 | Robert L Dixon JR | Grant A | 563 | $0 |
| May 13, 2026 | Steven H Collis | Grant A | 563 | $0 |
About ELV insider trading
This page tracks insider transactions for Elevance Health, Inc. (ELV) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.